Company: KEQU
Filing Date: 2025-07-02
Form Type: 10-K
Source: 0000055529-25-000026
Chunk: 202

Company: KEWAUNEE SCIENTIFIC CORP /DE/
Filing Date: 2025-07-02
Form: 10-K
Item: Item 1A
Chunk 202
---
21.1Subsidiaries of the Company(1)23.1Consent dated July 2, 2025 of Forvis Mazars, LLP, Independent Registered Public Accounting Firm(1)31.1Certification of Principal Executive Officer of the Company pursuant to Exchange Act Rule 13a-14(a) or Rule 15d-14(a)(1)31.2Certification of Principal Financial Officer of the Company pursuant to Exchange Act Rule 13a-14(a) or Rule 15d-14(a)(1)32.1Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002(1)32.2Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002(1)97.1Kewaunee Scientific Corporation Incentive-Based Compensation Recovery Policy(1)101.INSXBRL Instance Document(1)101.SCHXBRL Taxonomy Extension Schema Document(1)101.CALXBRL Taxonomy Extension Calculation Linkbase Document(1)101.DEFXBRL Taxonomy Extension Definition Linkbase Document(1)101.LABXBRL Taxonomy Extension Label Linkbase Document(1)101.PREXBRL Taxonomy Extension Presentation Linkbase Document(1)104Cover Page Interactive Data File (embedded within the Inline XBRL document)(1)

_____________

*    The referenced exhibit is a management contract or compensatory plan or arrangement.

(All other exhibits are either inapplicable or not required.)

Footnotes

(1)Filed with this Form 10-K with the Securities and Exchange Commission.

(2)Filed as an exhibit to the Kewaunee Scientific Corporation Quarterly Report to the Securities and Exchange Commission on Form 10-Q (Commission File No. 0-5286) for the quarterly period ended October 31, 2005, and incorporated herein by reference.

(3)Filed as an exhibit to the Kewaunee Scientific Corporation Annual Report to the Securities and Exchange Commission on Form 10-K (Commission File No. 0-5286) for the fiscal year ended April 30, 2023, and incorporated herein by reference.

59

(4)Filed as an exhibit to the Kewaunee Scientific Corporation Quarterly Report